Astrazeneca's Q1 Profit Falls 11% Despite Strong Diabetes Drug Growth

Diabetes drug growth helps spur AstraZeneca's top line modestly higher, however higher costs and patent expirations take their toll.

Topics:  astrazeneca   diabetes drug growth   higher   
BING NEWS:
  • AstraZeneca profit up on strong sales of cancer drugs
    British pharmaceutical giant AstraZeneca on Thursday said net profit jumped 21 percent in the first three months of the year thanks to strong growth in sales of cancer drugs.
    04/24/2024 - 8:41 pm | View Link
  • AstraZeneca beats revenue, profit estimates on resilient demand
    AstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by resilient demand for its oncology and rare blood disorder drugs.
    04/24/2024 - 6:10 pm | View Link
  • Sanders launches investigation into ‘unacceptable’ diabetes, weight loss drug prices
    Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s ...
    04/24/2024 - 2:07 pm | View Link
  • Artisan Global Equity Fund Q1 2024 Commentary
    Artisan Global Equity Fund's portfolio solidly outperformed the MSCI AC World Index. Click here to read the full fund letter.
    04/24/2024 - 2:30 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News